⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
LIXT News
Lixte Biotechnology Holdings, Inc. Common Stock
DealFlow Discovery Conference Announces Initial Lineup of Presenting Companies Ahead of Next Week's Event
accessnewswire.com
COE
ACCS
ASNS
DRTS
AREB
BKYI
FUFU
CJMB
DVLT
FBLG
MEHA
HCTI
INDO
JUNS
KAPA
LIXT
MYSZ
NNVC
HOVR
NOMA
OPTT
OWLS
PERF
PHIO
PROP
PRPO
SJ
LITM
SOPA
SNGX
XHLD
TYGO
TIVC
TRX
WGRX
WWR
ZENA
FLGC
DealFlow Discovery Conference Announces Initial Lineup of Presenting Companies Ahead of Next Week's Event
accessnewswire.com
COE
ACCS
ASNS
DRTS
AREB
BKYI
FUFU
CJMB
DVLT
FBLG
MEHA
HCTI
INDO
JUNS
KAPA
LIXT
MYSZ
NNVC
HOVR
NOMA
OPTT
OWLS
PERF
PHIO
PROP
PRPO
SJ
LITM
SOPA
SNGX
XHLD
TYGO
TIVC
TRX
WGRX
WWR
ZENA
FLGC
DE LA SOUL-LED “GOOD HEALTH SUMMIT” LAUNCHES FEBRUARY 19 AT MOREHOUSE COLLEGE
globenewswire.com
LIXT
LIXTE Biotechnology Attending the DealFlow Discovery Conference, January 28-29
globenewswire.com
LIXT
IBN Initiates Coverage of LIXTE Biotechnology Holdings Inc.
globenewswire.com
LIXT
LIXTE and its Collaborators Expand Clear Cell Ovarian Cancer Trial
globenewswire.com
LIXT
Spartan Capital Securities, LLC Serves as Placement Agent in Lixte Biotechnology Holdings, Inc.’s $4.3 Million Registered Direct Offering
globenewswire.com
LIXT
Lixte Biotechnology Holdings, Inc. Announces $4.3 Million Registered Direct Offering Priced at the Market Under Nasdaq Rules
globenewswire.com
LIXT
LIXTE's Strategy Comes Into Focus: Building an Oncology Platform Around Complementary Modalities
accessnewswire.com
LIXT
LIXTE Levels Up From PP2A Innovation to Multi-Modal Oncology
accessnewswire.com
LIXT